BRIEF published on 02/04/2025 at 10:40, 1 year 3 months ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 3 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF published on 10/01/2024 at 00:56, 1 year 7 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
BRIEF published on 10/01/2024 at 00:45, 1 year 7 months ago Valerio Therapeutics Reports Half-Year 2024 Financial Results and Strategic Updates Financial Results Emglev Acquisition VIO-01 Clinical Trial PlatON™ Platform Therapeutic Innovations
PRESS RELEASE published on 10/01/2024 at 00:40, 1 year 7 months ago Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
PRESS RELEASE published on 09/30/2024 at 22:40, 1 year 7 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
BRIEF published on 08/05/2024 at 19:23, 1 year 8 months ago Half-yearly review of the liquidity contract with Kepler Cheuvreux Liquidity Contract Transactions Kepler Cheuvreux AMF Valerio Therapeutics
PRESS RELEASE published on 08/05/2024 at 19:18, 1 year 8 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Valerio Therapeutics releases half-year liquidity contract statement revealing shares and trading volumes Liquidity Contract Shares AMF Decision Valerio Therapeutics Trading Volumes
BRIEF published on 06/05/2024 at 07:05, 1 year 10 months ago Minutes of the general meeting of Valerio Therapeutics Biotechnology Voting Results General Meeting Resolutions Valerio Therapeutics
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 10 months ago Inside Information / Other news releases Valerio Therapeutics reports successful Combined General Meeting with 48.1% quorum, adopting all resolutions. Consolidated vote results and meeting minutes to be available on the Company's website Euronext Growth Paris Biotechnology General Meeting Valerio Therapeutics DDR Drugs
Published on 05/04/2026 at 14:08, 13 minutes ago Critical Elements' 10,000-Metre Drill Program at Rose West Continues to Deliver Positive Results
Published on 05/04/2026 at 14:00, 21 minutes ago CHAR Tech Appoints Infrastructure & Capital Markets Veteran Kevin Melnyk as CFO and Reminds Shareholders of Upcoming AGM
Published on 05/04/2026 at 13:30, 51 minutes ago Eskay Mining Corp. Contracts Apex Geoscience Ltd. For Its Summer Exploration Program Within the British Columbia Golden Triangle
Published on 05/04/2026 at 13:54, 26 minutes ago EQS-Adhoc: Borussia Dortmund publishes preliminary figures for the third quarter (Q3) of the 2025/2026 financial year
Published on 05/04/2026 at 13:35, 45 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q1 2026 Financial Results
Published on 05/04/2026 at 13:20, 1 hour ago North Peak Resources Announces Agreement to Repurchase 1 Million Common Shares for Cancellation
Published on 05/04/2026 at 13:08, 1 hour 12 minutes ago MEDICLIN increases group operating result in the first quarter
Published on 05/04/2026 at 12:40, 1 hour 40 minutes ago EQS-Adhoc: SOWITEC group GmbH and the Joint Representative enter into a deferral agreement regarding a partial repayment of the bond 2018/2026
Published on 05/04/2026 at 09:51, 4 hours 29 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From April 27th 2026 to May 1st 2026
Published on 05/04/2026 at 08:45, 5 hours 36 minutes ago Air Liquide divests its biogas production activities in four countries
Published on 04/30/2026 at 20:00, 3 days 18 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days 19 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days 19 hours ago Capital increase through exercise of subscription rights
